(Q35561659)

8 August 2017

1 reference

title

Chemokines and tuberculosis (English)

1 reference

8 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00054-6

22 March 2024

1

Holly M Scott Algood

1 reference

8 August 2017

John Chan

2

1 reference

8 August 2017

Holly M. Scott Algood

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563349

22 March 2024

JoAnne L. Flynn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563349

22 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14563349

22 March 2024

publication date

1 December 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S1359610103000546?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00054-6

https://api.elsevier.com/content/article/PII:S1359610103000546?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00054-6

Cytokine and Growth Factor Reviews

22 March 2024

published in

1 reference

8 August 2017

14

1 reference

8 August 2017

6

1 reference

8 August 2017

467-477

1 reference

Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Disseminated tuberculosis in interferon gamma gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

CD8+ T cells in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

CD4(+) T cell and natural killer cell-dependent killing of Mycobacterium tuberculosis by human monocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

T helper cell populations, cytokine dynamics, and pathology of the schistosome egg granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

In situ characterization of the human host response to Leishmania panamensis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Granulomas induced by living agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The schistosome granuloma: an immunoregulatory organelle

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Immunopathology of leprosy granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Functional subsets of memory T cells identified by CCR7 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The role of chemokine receptors in primary, effector, and memory immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Downregulation by tumor necrosis factor-α of monocyte CCR2 expression and monocyte chemotactic protein-1-induced transendothelial migration is antagonized by oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

ExperimentalMycobacterium tuberculosisInfection of Cynomolgus Macaques Closely Resembles the Various Manifestations of HumanM. tuberculosisInfection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Gene expression in the tuberculous granuloma: analysis by laser capture microdissection and real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2803%2900054-6

7 January 2021

Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ

series ordinal

32

1 reference

https://api.crossref.org/works/10.1016/S1359-6101(03)00054-6

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference